Prothena
PRTA
#7789
Rank
HK$3.48 B
Marketcap
HK$66.59
Share price
1.92%
Change (1 day)
22.23%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2026 (TTM): -HK$0.73 Billion

According to Prothena's latest financial reports the company's current earnings are HK$57.94 Million. In 2025 the company made an earning of -HK$1.45 Billion a decrease over its 2024 earnings that were of -HK$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.73 Billion-49.76%
2025 -HK$1.45 Billion19.41%
2024 -HK$1.22 Billion-19.09%
2023 -HK$1.5 Billion45.21%
2022 -HK$1.04 Billion-282.78%
2021 HK$0.56 B-163.84%
2020 -HK$0.89 Billion33.94%
2019 -HK$0.67 Billion-44.78%
2018 -HK$1.2 Billion-0.97%
2017 -HK$1.21 Billion-3.33%
2016 -HK$1.25 Billion99.17%
2015 -HK$0.63 Billion1102.24%
2014 -HK$52.15 Million-83.55%
2013 -HK$0.32 Billion-2.37%
2012 -HK$0.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amarin Corporation
AMRN
-HK$0.25 Billion-66.58%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
HK$6.82 B-1,033.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$1.86 B-354.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland